Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension
收藏官方服务：
资源简介：
The dysfunction of the renin-angiotensin system (RAS) has been observed in coronavirus infection disease (COVID-19) patients, but whether RAS inhibitors, such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor blockers (ARBs), are associated with clinical outcomes remains unknown. COVID-19 patients with hypertension were enrolled to evaluate the effect of RAS inhibitors.
提供机构：
ImmPort创建时间：
2020-07-31
